Dawn Edwards

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Laurie A. Lee, Zelie Bailes, Neil Barnes et al. · The Lancet Respiratory Medicine · 2020 · 258 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +12

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials

Philippe Gevaert, Martin Desrosiers, Marjolein Cornet et al. · The Lancet · 2025 · 70 citations

Medicine, Otolaryngology, Pharmacotherapy +8

Using Bayesian Dynamic Borrowing to Maximize the Use of Existing Data: A Case-Study

Dawn Edwards, Nicky Best, J. H. Crawford et al. · Therapeutic Innovation & Regulatory Science · 2023 · 13 citations · Full text

Medicine, Pharmacology, Bayesian Data Analysis +15

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy et al. · The Lancet Haematology · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacology +13